Nurix Therapeutics Inc (NRIX)
14.69
+0.15
(+1.03%)
USD |
NASDAQ |
Mar 28, 16:00
14.41
-0.28
(-1.91%)
Pre-Market: 20:00
Nurix Therapeutics Revenue (TTM): 76.99M for Nov. 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
November 30, 2023 | 76.99M |
August 31, 2023 | 68.61M |
May 31, 2023 | 60.94M |
February 28, 2023 | 41.69M |
November 30, 2022 | 38.63M |
August 31, 2022 | 39.24M |
May 31, 2022 | 38.70M |
February 28, 2022 | 34.36M |
Date | Value |
---|---|
November 30, 2021 | 29.75M |
August 31, 2021 | 29.04M |
May 31, 2021 | 22.88M |
February 28, 2021 | 19.97M |
November 30, 2020 | 17.82M |
August 31, 2020 | 12.99M |
May 31, 2020 | 19.49M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
12.99M
Minimum
Aug 2020
76.99M
Maximum
Nov 2023
36.74M
Average
34.36M
Median
Feb 2022
Revenue (TTM) Benchmarks
Biogen Inc | 9.836B |
UroGen Pharma Ltd | 82.71M |
Deciphera Pharmaceuticals Inc | 163.36M |
Apellis Pharmaceuticals Inc | 396.59M |
CEL-SCI Corp | -- |